NNVC (NanoViricides Inc.) יחס שווי שוק לשווי בספרים

NanoViricides, Inc. (NNVC) develops advanced antiviral agents using proprietary nanotechnologies to disrupt pathogen structures while strictly adhering to environmental bio-waste disposal regulations. The market value dynamics of the asset, which currently stands at 3.58, are illustrated below. NanoViricides, Inc. (NNVC) is building a defense system by integrating "smart traps" into influenza and herpes medications to physically eliminate infections.

This indicator mathematically captures the sensitivity of market expectations to actual capital volume. It compares the current share price with the book value of net assets, filtering out speculative noise. For NanoViricides, Inc. (NNVC), this calculation confirms the value of its own manufacturing facility in Connecticut. Analyzing the price-to-book ratio allows for the determination of the premium paid for production capacities. The dynamics of this metric reveal the fair value of the business.